CRISPR Therapeutics AG (NASDAQ:CRSP)

54.63
BATS BZX Real-Time Price
As of 1:54pm ET
 +2.41 / +4.62%
Today’s Change
42.51
Today|||52-Week Range
169.76
-27.91%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 117.00, with a high estimate of 220.00 and a low estimate of 52.00. The median estimate represents a +114.17% increase from the last price of 54.63.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.22
Sales
$2.2M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.39%
 
 
 
 
 
 
Growthannually -290.30%
 
 
 
 
 
 

Sales

Growthquarterly 135.37%
 
 
 
 
 
 
Growthannually -94.28%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.